ISRCTN47368803已完成不适用
IBS-C Study A2306
ovartis Pharmaceuticals Corporation0 个研究点目标入组 0 人开始时间: 2003年9月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Females, 18 to 65 years, with IBS-C (Irritable Bowel Syndrome with constipation)
排除标准
- •Not provided at time of registration.
研究者
相似试验
Unknown
不适用
The Effect of CanChew® Cannabidiol (CBD) Containing Chewing Gum on Irritable Bowel SyndromeIrritable Bowel SyndromeNCT03003260Wageningen University40
已完成
不适用
A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)Irritable Bowel SyndromeNCT04072991Sheffield Teaching Hospitals NHS Foundation Trust101
已完成
4 期
To study effect of IBS Sure plus tablet for IBS Acidity diarrhoea loss of appetiteCTRI/2022/04/041561Healing Hands and Herbs
已完成
2 期
A Randomized, Placebo-controlled, Double-blind, Parallel-group, Exploratory Study of DSP-6952 in Patients with Irritable Bowel Syndrome with ConstipatioIrritable bowel syndrome with constipationJPRN-jRCT2080221995Sumitomo Dainippon Pharma Co.,Ltd.175
终止
3 期
52-Week Efficacy and Safety Study of Ibodutant in Women With Irritable Bowel Syndrome With Diarrhea (IBS-D)Irritable Bowel Syndrome With DiarrheaNCT02120027Menarini Group558